New Brain Treatment Helps Depression Patients in Arkansas

For nearly a third of people living with depression, traditional medication and therapy simply don't work, leaving millions searching for answers. Now, the University of Arkansas for Medical Sciences is offering new hope through a groundbreaking brain treatment that's helping patients feel like themselves again.

UAMS recently became one of the first centers in the country to offer the SAINT neuromodulation system, an FDA-approved treatment specifically designed for treatment-resistant depression. Unlike medications that work at the cellular level, SAINT uses targeted magnetic stimulation to reset the brain's neural circuits involved in depression.

"For my patients, they'll tell me, once their depression is better, I feel like myself again, and that is the goal," said Dr. Amy Grooms, a psychiatrist at UAMS who directs the program. The treatment works by restoring how the brain normally functions, offering relief when nothing else has helped.

What makes SAINT different is its personalization and speed. Each patient receives an fMRI brain scan that maps their unique neural circuits, allowing doctors to target the exact spot where stimulation will be most effective. No two brains are alike, and SAINT accounts for that.

The treatment itself is surprisingly quick but intensive. Patients receive ten 10-minute sessions per day for five consecutive days. That's 50 total sessions packed into one week, compared to traditional brain stimulation therapies that can take months.

Why This Inspires

Treatment-resistant depression affects roughly 30% of Americans with depression, a staggering number of people who've tried everything without success. For these patients, each failed medication or therapy can feel like another door closing.

SAINT represents a fundamentally different approach backed by neuroscience and FDA approval. It's not experimental or unproven. It's a genuine breakthrough that's helping people reclaim their lives after years of struggling.

The fact that UAMS brought this technology to Arkansas so quickly means patients in the region don't have to travel across the country for cutting-edge care. Hope is now closer to home.

People interested in learning whether SAINT might help them can contact UAMS directly to discuss their treatment history and options.